BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21365264)

  • 1. Risk factors associated with early- versus late-onset implantable cardioverter-defibrillator infections.
    Sohail MR; Hussain S; Le KY; Dib C; Lohse CM; Friedman PA; Hayes DL; Uslan DZ; Wilson WR; Steckelberg JM; Baddour LM;
    J Interv Card Electrophysiol; 2011 Aug; 31(2):171-83. PubMed ID: 21365264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections.
    Sohail MR; Uslan DZ; Khan AH; Friedman PA; Hayes DL; Wilson WR; Steckelberg JM; Stoner S; Baddour LM
    J Am Coll Cardiol; 2007 May; 49(18):1851-9. PubMed ID: 17481444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Permanent pacemaker and implantable cardioverter defibrillator infections: seven years of diagnostic and therapeutic experience of a single center.
    Cengiz M; Okutucu S; Ascioglu S; Sahin A; Aksoy H; Sinan Deveci O; Baris Kaya E; Aytemir K; Kabakci G; Tokgozoglu L; Ozkutlu H; Oto A
    Clin Cardiol; 2010 Jul; 33(7):406-11. PubMed ID: 20641117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated procedures at the generator pocket are a determinant of implantable cardioverter-defibrillator infection.
    Arana-Rueda E; Pedrote A; Frutos-López M; Acosta J; Jauregui B; García-Riesco L; Arce-León Á; Gómez-Pulido F; Sánchez-Brotons JA; Gutiérrez-Carretero E; de Alarcón-González A
    Clin Cardiol; 2017 Oct; 40(10):892-898. PubMed ID: 28636098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting risk of endovascular device infection in patients with Staphylococcus aureus bacteremia (PREDICT-SAB).
    Sohail MR; Palraj BR; Khalid S; Uslan DZ; Al-Saffar F; Friedman PA; Hayes DL; Lohse CM; Wilson WR; Steckelberg JM; Baddour LM
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):137-44. PubMed ID: 25504648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Device-related infection in de novo transvenous implantable cardioverter-defibrillator Medicare patients.
    El-Chami MF; Jacobsen CM; Griffiths RI; Hansen LK; Wold N; Amorosi SL; Stivland TM; Knight BP; Weiss R; Mark GE; Biffi M; Probst V; Lambiase PD; Miller MA; Baddour LM
    Heart Rhythm; 2021 Aug; 18(8):1301-1309. PubMed ID: 33887452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factor analysis of permanent pacemaker infection.
    Sohail MR; Uslan DZ; Khan AH; Friedman PA; Hayes DL; Wilson WR; Steckelberg JM; Stoner SM; Baddour LM
    Clin Infect Dis; 2007 Jul; 45(2):166-73. PubMed ID: 17578774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with gram-negative bacteremia.
    Uslan DZ; Sohail MR; Friedman PA; Hayes DL; Wilson WR; Steckelberg JM; Baddour LM
    Clin Infect Dis; 2006 Sep; 43(6):731-6. PubMed ID: 16912947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for explantation due to infection after sacral neuromodulation: a multicenter retrospective case-control study.
    Myer ENB; Petrikovets A; Slocum PD; Lee TG; Carter-Brooks CM; Noor N; Carlos DM; Wu E; Van Eck K; Fashokun TB; Yurteri-Kaplan L; Chen CCG
    Am J Obstet Gynecol; 2018 Jul; 219(1):78.e1-78.e9. PubMed ID: 29630890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular implantable electronic device infection in patients with Staphylococcus aureus bacteremia.
    Uslan DZ; Dowsley TF; Sohail MR; Hayes DL; Friedman PA; Wilson WR; Steckelberg JM; Baddour LM
    Pacing Clin Electrophysiol; 2010 Apr; 33(4):407-13. PubMed ID: 19793360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wound haematoma following defibrillator implantation: incidence and predictors in the Shockless Implant Evaluation (SIMPLE) trial.
    Masiero S; Connolly SJ; Birnie D; Neuzner J; Hohnloser SH; Vinolas X; Kautzner J; O'Hara G; VanErven L; Gadler F; Wang J; Mabo P; Glikson M; Kutyifa V; Wright DJ; Essebag V; Healey JS;
    Europace; 2017 Jun; 19(6):1002-1006. PubMed ID: 27353323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Device infections in implantable cardioverter defibrillators versus permanent pacemakers: A systematic review and meta-analysis.
    Rattanawong P; Kewcharoen J; Mekraksakit P; Mekritthikrai R; Prasitlumkum N; Vutthikraivit W; Putthapiban P; Dworkin J
    J Cardiovasc Electrophysiol; 2019 Jul; 30(7):1053-1065. PubMed ID: 30938929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A propensity matched case-control study comparing efficacy, safety and costs of the subcutaneous vs. transvenous implantable cardioverter defibrillator.
    Honarbakhsh S; Providencia R; Srinivasan N; Ahsan S; Lowe M; Rowland E; Hunter RJ; Finlay M; Segal O; Earley MJ; Chow A; Schilling RJ; Lambiase PD
    Int J Cardiol; 2017 Feb; 228():280-285. PubMed ID: 27865198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences.
    Nery PB; Fernandes R; Nair GM; Sumner GL; Ribas CS; Menon SM; Wang X; Krahn AD; Morillo CA; Connolly SJ; Healey JS
    J Cardiovasc Electrophysiol; 2010 Jul; 21(7):786-90. PubMed ID: 20102431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of leukocytosis after cardiac device implantation.
    Tompkins C; Cheng A; Brinker JA; Marine JE; Nazarian S; Spragg DD; Sinha S; Halperin H; Tomaselli GF; Berger RD; Calkins H; Henrikson CA
    Am J Cardiol; 2013 Jun; 111(11):1608-12. PubMed ID: 23523060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes in patients with cardiovascular implantable electronic devices and bacteremia caused by Gram-positive cocci other than Staphylococcus aureus.
    Madhavan M; Sohail MR; Friedman PA; Hayes DL; Steckelberg JM; Wilson WR; Baddour LM;
    Circ Arrhythm Electrophysiol; 2010 Dec; 3(6):639-45. PubMed ID: 20852296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection.
    Sohail MR; Uslan DZ; Khan AH; Friedman PA; Hayes DL; Wilson WR; Steckelberg JM; Jenkins SM; Baddour LM
    Mayo Clin Proc; 2008 Jan; 83(1):46-53. PubMed ID: 18174000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased late complex device infections are determined by cardiac resynchronization therapy-defibrillator infection.
    Unsworth JD; Zaidi A; Hargreaves MR
    Europace; 2015 Nov; 17(11):1708-11. PubMed ID: 25883081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis.
    Polyzos KA; Konstantelias AA; Falagas ME
    Europace; 2015 May; 17(5):767-77. PubMed ID: 25926473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infections of implantable cardiac rhythm devices: predisposing factors and outcome.
    Ipek EG; Guray U; Demirkan B; Guray Y; Aksu T
    Acta Cardiol; 2012 Jun; 67(3):303-10. PubMed ID: 22870738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.